Integrated Microfluidic Platform for Biomarker Detection and Serum Self‑Separation (Biomarker Detection and Self‑Separation of Serum during Capillary Flow, Tech ID: 17‑020)
Technology Overview: This technology enables simultaneous biomarker detection and passive serum separation within a microfluidic device using capillary flow. The system eliminates external centrifugation or preprocessing steps by leveraging microchannel geometry and surface chemistry to separate serum directly from whole blood. Integrated detection elements enable rapid, point‑of‑care biomarker analysis from small sample volumes, improving usability in clinical and field settings.
Industry Pain Point: Standard blood testing requires centralized labs, multiple processing steps, and significant turnaround time.
NJIT Solution: This platform delivers on‑chip serum separation and biomarker detection, enabling fast, decentralized diagnostics.
Key Features & Advantages
- Passive serum separation without centrifugation
- Integrated biomarker detection
- Minimal sample volume required
- Suitable for point‑of‑care use
Development Stage: TRL 5–6 – Functional device prototypes validated.
Target Markets
- Point‑of‑care diagnostics
- Clinical testing devices
- Remote and resource‑limited healthcare
Market Opportunity
- Global point‑of‑care diagnostics market (2026): ~$45B
- CAGR: ~9–10%
- Projected market size (2035): ~$95–100B
Commercial & IP Details
Inventors: Eon Soo Lee, Bharath Babu Nunna